Myriad Genetics Inc (MYGN)

CapEx to Revenue

1.10%

Quarterly · Period ending:

MYGN logo

MYGN CapEx to Revenue

Latest reported1.10%
MYGN Quarterly CapEx/Revenue (0.00% → 1.10%)
High-resolution chart · PNG

MYGN capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
1.1012%
2.6946%
2.8599%
1.3612%
3.2379%
2.7055%
2.8015%
1.6409%
2.4586%
4.2532%
6.8667%
9.1193%
10.2452%
12.9691%
8.2115%
11.3171%
3.7368%
3.8205%
2.1144%
1.7932%
2.3759%
4.1017%
0%
1.0331%
2.5751%
1.8293%
1.7427%
0.7515%
0.65%
1.4312%
1.2915%
0.6426%
0.9236%
1.5838%
1.1176%
0.8949%
0.3491%
0.7618%
1.2214%
0.8451%
1.1803%
0.3675%
0.5691%
0.545%
1.0506%
2.4444%
3.2538%
6.8128%
2.4464%
0.8501%
1.3883%
2.6004%
1.603%
1.0059%
3.0488%
1.8443%
1.5733%
1.5411%
3.1406%
1.9094%
2.3368%
1.7172%
1.0603%
2.1326%
0%
1.374%
4.6816%
1.8526%
0%
0%
3.0672%
1.2682%
2.3409%
2.6115%
8.5898%
6.7998%
6.0293%
3.4%
12.8854%
7.3935%
5.7268%
8.7021%
8.5547%
3.6394%
16.4546%
3.587%
4.6693%
4.8414%
6.6813%
2.5225%
7.676%
10.5544%
10.5005%
5.6564%
14.4368%
19.4701%
30.0108%
5.5131%
8.3305%
5.8757%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.